Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
[Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries]
Bull Acad Natl Med. 1990 Nov;174(8):1209-19; discussion 1219-21. Unique Identifier : AIDSLINE MED/91243023 Gentilini M; Chieze F; Departement des maladies infectieuses et tropicales et de sante; publique, Unite INSERN 313, Groupe hospitalier; Pitie-Salpetriere, Paris.
Abstract:
The assessment of the socio-economical aspects of the human immunodeficiency virus (HIV) infection is difficult because of the relative scarcity of information. This study addresses mainly the socio-economic aspects of the AIDS pandemic in the inter-tropical zone of Africa, which, at the moment, constitutes the epicenter of the disease. In the absence of a possible radical treatment, the HIV infection prevalence should range between 25 and 30 million individuals by the year 2000 in the world, and the number of cases of AIDS, between 5 and 6 million, among which 4 to 5 million in the developing world alone. At the current rate, the overmortality rate related to AIDS in Africa is estimated at 0.1%, which should result in a drop by 30% of the Gross National Products advance (GNP). Each case of AIDS in Africa leads to a loss of productivity of 8.8 years. Already, losses caused by AIDS screening and its medical treatment in five countries of Central Africa should exceed the total amount of the foreign assistance received by each country. The estimated economic weight of the AIDS attendance is 15 to 20 times more heavy for a developing country than for an industralized one. Overcoming economically the cost of AIDS is an objective impossible to reach for deprived countries.
Keywords: Acquired Immunodeficiency Syndrome/*ECONOMICS/PSYCHOLOGY Adult Africa Asia Child *Developing Countries English Abstract Human HIV Infections/*ECONOMICS/PSYCHOLOGY Socioeconomic Factors South America JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL 910930
M9190694
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.